Commerzbank AG announced Evonik Industries (ETR:EVK), bumping up its stock price target to 33.00EUR today
- Updated: February 11, 2017
In a report released on 02/12/2017 Commerzbank AG increased the stock price target of Evonik Industries (ETR:EVK) to 33.00EUR reporting a possible upside of 0.11%.
Previously on 2/11/2017, Commerzbank AG released a statement about Evonik Industries (ETR:EVK) increased the target price from 0.00EUR to 33.00EUR. At the time, this indicated a possible upside of 0.11%.
Just yesterday Evonik Industries (ETR:EVK) traded 2.13% higher at 29.85EUR. Evonik Industries’s 50-day moving average is 2.24EUR and its 200-day moving average is 2.32EUR. The last stock price is up 3.50% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has increased 0.06% over the same time period. 711 shares of EVK traded hands, down from an average trading volume of 5,163
Recent Performance Chart
Evonik Industries has 52 week low of 1.35EUR and a 52 week high of 2.88EUR with a PE ratio of 4.38 and has a market capitalization of 0 EUR.
Brief Synopsis On Evonik Industries (ETR:EVK)
Evonik Industries AG (Evonik) is a Germany-based company engaged in the specialty chemicals sector. The Company's activities are divided in four segments: Nutrition & Care, produces specialty chemicals, mainly for use in consumer goods for daily needs and food, as well as in animal nutrition and healthcare products; Resource Efficiency, offers material solutions for environment-friendly and energy-efficient products used in the automotive, adhesives and construction industries, among others; Performance Materials, produces polymer materials and their intermediates, mainly for the rubber, plastics and agriculture sectors, and Services, includes site management, utilities and waste management, as well as technical, process technology, engineering and logistics services for the chemicals segments and external customers at Company's sites, among others. It is a subsidiary of RAG Stiftung.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.